[Specifics for anticoagulation with atrial fibrillation: triple therapy and perioperative bridging]

Area of Science:

• Cardiology
• Pharmacology
• Internal Medicine

Background:

• Atrial fibrillation necessitates anticoagulation.
• Concurrent indications for antiplatelet therapy (e.g., post-percutaneous coronary intervention) or surgery complicate management.
• Limited clinical data exists for these complex scenarios.

Purpose of the Study:

• To provide a pragmatic treatment approach for managing anticoagulation in patients with atrial fibrillation facing additional therapeutic needs.
• To discuss recent literature regarding the balance of risks in these patient populations.

Main Methods:

• Review of current clinical literature.
• Discussion of individualized treatment strategies.
• Risk-benefit analysis of anticoagulation and antiplatelet therapy.

Main Results:

• An individualized approach is essential, considering both bleeding risk and thromboembolic risk.
• Current literature provides limited direct evidence, necessitating careful clinical judgment.

Conclusions:

• Effective management requires a tailored strategy for each patient.
• Balancing anticoagulation, antiplatelet therapy, and surgical needs is paramount to optimize outcomes in atrial fibrillation patients.